1. Sia CH, Ko J, Zheng H, Ho AF, Foo D, Foo LL, Lim PZ, Liew BW, Chai P, Yeo TC, Yip JWL, Chua T, Chan MY, Tan JWC, Bulluck H, Hausenloy DJ. Association of body mass index, metabolic health status and clinical outcomes in acute myocardial infarction patients: a national registry-based study. Front Cardiovasc Med. 2023 Jun 26;10:1142078.

2. Wong JJ, Annie L, Jiang Y, Yeo KK, Yap J. Understanding patterns, predictors and long-term outcomes of patients with recurrent myocardial infarction hospitalizations. Journal of the American College of Cardiology. 2023 Mar 7;81(8_Supplement):1242-.

3. Seah A, Ho AF, Soh S, Zheng H, Pek PP, Morgan GG, Ong ME, Aik J. Ambient temperature and hospital admissions for non-ST segment elevation myocardial infarction in the tropics. Science of The Total Environment. 2022 Dec 1;850:158010.

4. Koo CY, Zheng H, Tan LL, Foo LL, Hausenloy DJ, Chng WJ, Lee SC, Richards AM, Ling LH, Lim SL, Lee CH. Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction. Biomedicines. 2022 Oct 23;10(11):2681.

5. Liu X, Tou NX, Gao Q, Gwee X, Wee SL, Ng TP. Frailty and risk of cardiovascular disease and mortality. Plos one. 2022 Sep 19;17(9):e0272527.

6. Sia CH, Zheng H, Ko J, Ho AF, Foo D, Foo LL, Lim PZ, Liew BW, Chai P, Yeo TC, Tan HC. Comparison of the modified Singapore myocardial infarction registry risk score with GRACE 2.0 in predicting 1-year acute myocardial infarction outcomes. Scientific Reports. 2022 Aug 22;12(1):14270.

7. Koo GP, Zheng H, Pek PP, Hughes F, Lim SL, Yeo JW, Ong ME, Ho AF. Clustering of environmental parameters and the risk of acute myocardial infarction. International Journal of Environmental Research and Public Health. 2022 Jul 11;19(14):8476.

8. Sia CH, Ko J, Zheng H, Ho AF, Foo D, Foo LL, Lim PZ, Liew BW, Chai P, Yeo TC, Yip JW. Comparison of mortality outcomes in Acute myocardial infarction patients with or without Standard Modifiable Cardiovascular Risk factors. Frontiers in cardiovascular medicine. 2022 Apr 14;9:876465.

9. Koo CY, Zheng H, Tan LL, Foo LL, Seet R, Chong JH, Hausenloy DJ, Chng WJ, Richards AM, Lee CH, Chan MY. Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or stroke. Scientific Reports. 2021 Oct 27;11(1):21167.

10. Sia CH, Ko J, Zheng H, Ho AF, Foo D, Foo LL, Lim PZ, Liew BW, Chai P, Yeo TC, Tan HC. Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention. Scientific reports. 2021 Mar 19;11(1):6466. 

1. Koo GP, Zheng H, Aik JC, Tan BY, Sharma VK, Sia CH, Ong ME, Ho AF. Clustering of Environmental Parameters and the Risk of Acute Ischaemic Stroke. International Journal of Environmental Research and Public Health. 2023 Mar 11;20(6):4979.

2. Ho JS, Sia CH, Zheng H, Tan BY, Ho AF, Yeo LL, Chan MY. Interplay between post-myocardial infarction ejection fraction and atrial fibrillation: implications for ischemic stroke. European Heart Journal. 2023 Feb 1;44(Supplement_1):ehac779-060.

3. Koh YS, Subramaniam M, Matchar DB, Hong SI, Koh GC. The associations between caregivers’ psychosocial characteristics and caregivers’ depressive symptoms in stroke settings: a cohort study. BMC psychology. 2022 Dec;10(1):1-0.

4. Ho AF, Tan BY, Zheng H, Leow AS, Pek PP, Liu N, Raju Y, Yeo LL, Sharma VK, Ong ME, Aik J. Association of air pollution with acute ischemic stroke risk in Singapore: a time-stratified case-crossover study. International Journal of Stroke. 2022 Oct;17(9):983-9.

5. Liu X, Tou NX, Gao Q, Gwee X, Wee SL, Ng TP. Frailty and risk of cardiovascular disease and mortality. Plos one. 2022 Sep 19;17(9):e0272527.

6. Tan BY, Ho JS, Ho AF, Pek PP, Leow AS, Raju Y, Sia CH, Yeo LL, Sharma VK, Ong ME, Aik J. Ambient Air Pollution and Acute Ischemic Stroke—Effect Modification by Atrial Fibrillation. Journal of Clinical Medicine. 2022 Sep 15;11(18):5429.

7. Ho AF, Lim MJ, Zheng H, Leow AS, Tan BY, Pek PP, Raju Y, Seow WJ, Yeo TT, Sharma VK, Aik J. Association of ambient air pollution with risk of hemorrhagic stroke: A time-stratified case crossover analysis of the Singapore stroke registry. International Journal of Hygiene and Environmental Health. 2022 Mar 1;240:113908.

8. Tan TH, Zheng H, Cheo T, Tey J, Soon YY. Risk of Stroke in Nasopharyngeal Cancer Survivors: A National Registry-Based Population Cohort Study. Neurology. 2022 Jan 11;98(2):e115-24.

9. Koo CY, Zheng H, Tan LL, Foo LL, Seet R, Chong JH, Hausenloy DJ, Chng WJ, Richards AM, Lee CH, Chan MY. Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or stroke. Scientific Reports. 2021 Oct 27;11(1):21167.

10. Xu H, De Silva DA, Woon FP, Ong ME, Matchar DB, Bettger JP, Laskowitz DT, Xian Y. Changes in informed consent policy and treatment delays in stroke thrombolysis. Journal of Stroke and Cerebrovascular Diseases. 2021 Mar 1;30(3):105551.

1. Norris RP, Dew R, Greystoke A, Todd A, Sharp L. Socio-economic Inequalities in Novel NSCLC Treatments During the Era of Tumor Biomarker Guided Therapy: A Population-based Cohort Study in a Publicly Funded Healthcare System. J Thorac Oncol. 2023 May 3:S1556-0864(23)00522-1. 

2. Gannon MR, Park MH, Miller K, Dodwell D, Horgan K, Clements K, Medina J, Cromwell DA. Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England. Cancer Epidemiol. 2023 Apr;83:102337. 

3. Kang J, Cairns J. "Don't Think Twice, It's All Right": Using Additional Data to Reduce Uncertainty Regarding Oncologic Drugs Provided Through Managed Access Agreements in England. Pharmacoecon Open. 2023 Jan;7(1):77-91. 

4. Hassan S, Miles A, Rachet B, Morris M. Variations in the Type of Adjuvant Chemotherapy Among Stage III Colon Cancer Patients in England. J Gastrointest Cancer. 2023 Jan 5. doi: 10.1007/s12029-022-00899-9. Epub ahead of print. PMID: 36602753.

5. Board R, Smittenaar R, Lawton S, Liu H, Juwa B, Chao D, Corrie P. Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018. International Journal of Cancer. 2021 Feb 15;148(4):868-75.  

6. Gannon MR, Dodwell D, Jauhari Y, Horgan K, Clements K, Medina J, Cromwell DA. Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England. Journal of geriatric oncology. 2020 Jun 1;11(5):836-42.

7. Bright CJ, Lawton S, Benson S, Bomb M, Dodwell D, Henson KE, McPhail S, Miller L, Rashbass J, Turnbull A, Smittenaar R. Data Resource Profile: The Systemic Anti-Cancer Therapy (SACT) dataset. Int J Epidemiol. 2020 Feb 1;49(1):15-15l. [Corrigendum to article - Int J Epidemiol. 2020 Feb 1;49(1):354.]

8. McDonald L, Sammon C, Carroll R, Harish A, C AS, Tyas D, Ramagopalan SV. Consistency of recording of chemotherapy cycles in the National Cancer Registration and Analysis Service Systemic Anti-Cancer Therapy database and the Hospital Episode Statistics Admitted Patient Care database. Future Oncol. 2020 Jan;16(3):4455-4460. doi: 10.2217/fon-2019-0669. 

9. Adizie JB, Khakwani A, Beckett P, Navani N, West D, Woolhouse I, Harden SV. Stage III non-small cell lung cancer management in England. Clinical oncology. 2019 Oct 1;31(10):688-96.

10. Jørgensen J, Kefalas P. Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate. J Mark Access Health Policy. 2019 Jun 27;7(1):1635842. 

1. Thomas CE, Adibi JJ, Kuipers AL, Diergaarde B, Luu HN, Jin A, Koh WP, Gao YT, Adams-Haduch J, Wang R, Lokshin A. Soluble CD137 and risk of hepatocellular carcinoma: nested case–control studies in cohorts in Shanghai and Singapore. British Journal of Cancer. 2023 Jun 15;128(11):2081-8.

2. Peres MA, Huihua L, Antunes JL, Perea LM, Iyer NG, Peres KG. Time trend and Age-Period-Cohort analysis of potentially HPV-related oral and pharyngeal cancer incidence in Singapore between 1968 and 2017. Oral Oncology. 2023 Jan 1;136:106272.

3. Yu YC, Paragomi P, Jin A, Wang R, Schoen RE, Koh WP, Yuan JM, Luu HN. Dietary nonstarch polysaccharide intake and risk of colorectal cancer: findings from the Singapore Chinese health study. Cancer research communications. 2022 Oct 31;2(10):1304-11.

4. Soo R, Mery L, Bardot A, Kanesvaran R, Keong TC, Pongnikorn D, Prasongsook N, Hutajulu SH, Irawan C, Ab Manan A, Thiagarajan M. Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries. ESMO open. 2022 Oct 1;7(5):100560.

5. Htun HL, Lian W, Wong J, Tan EJ, Foo LL, Ong KH, Lim WY. Classic myeloproliferative neoplasms in Singapore: A population-based study on incidence, trends, and survival from 1968 to 2017. Cancer Epidemiology. 2022 Aug 1;79:102175.

6. Sheng LT, Jiang YW, Pan A, Koh WP. Dietary total antioxidant capacity and mortality outcomes: The Singapore Chinese Health Study. European Journal of Nutrition. 2022 Aug;61(5):2375-82.

7. Lei M, Adambekov S, Edwards RP, Wang R, Yuan JM, Kalix E, Lopa S, Linkov F. Endometrial cancer risk factors in Singapore Chinese: a prospective cohort study. Annals of Epidemiology. 2022 Jul 1;71:9-14.

8. Paragomi P, Wang R, Jin A, Yu YC, Brand RE, Sheng LT, Pan A, Koh WP, Yuan JM, Luu H. Composite dietary antioxidant index and the risk of pancreatic cancer: Findings from a prospective cohort study. Cancer Research. 2022 Jun 15;82(12_Supplement):3667-.

9. Yu YC, Paragomi P, Wang R, Jin A, Schoen RE, Sheng LT, Pan A, Koh WP, Yuan JM, Luu HN. Composite dietary antioxidant index and the risk of colorectal cancer: findings from the Singapore Chinese Health Study. International Journal of Cancer. 2022 May 15;150(10):1599-608.

10. Tan TH, Zheng H, Cheo T, Tey J, Soon YY. Risk of Stroke in Nasopharyngeal Cancer Survivors: A National Registry-Based Population Cohort Study. Neurology. 2022 Jan 11;98(2):e115-24.